RxDoctor Payments Data

Slessor Toh-Fombang

Psychiatric/Mental Health · Columbus, OHNPI 1205509452

Payments from drug & device makers

$658in general payments, 2019–2025

Across 36 payments — averaging $18.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$219
  • Johnson & Johnson$89
  • Neurocrine Biosciences, Inc.$65
  • Otsuka America Pharmaceutical, Inc.$65
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$59
  • Lundbeck LLC$49
  • plus $111 from 4 others

What the payments were for

  • Food & beverage$658100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$658 in reported general payments places this provider in the 50th percentile of 1,808 psychiatric/mental health providers in Ohio.

See all psychiatric/mental health providers in Ohio

Medicare billing

Part B allowed, 2024
$588
Medicare patients
12
Services billed
13

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl25$34,357
Abilify MaintenaAripiprazole12$28,032
TrintellixVortioxetine Hydrobromide20$13,922
Venlafaxine Hcl ErVenlafaxine Hcl33$4,413
Bupropion XlBupropion Hcl17$2,794
Aripiprazole44$2,713
Lurasidone Hcl23$2,186
Vilazodone Hcl14$2,107
Hydroxyzine Hcl45$1,175
Quetiapine Fumarate58$1,161
Duloxetine Hcl32$959
Buspirone Hcl65$920
Prazosin Hcl28$766
Trazodone Hcl79$623
Amitriptyline Hcl23$604

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$219$34,35725 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena$65$28,03212 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 1,808 psychiatric/mental health providers in Ohio.

Other psychiatric/mental health in Columbus

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →